McDermott Will & Schulte advises H.I.G. Capital in the sale of Celerion | McDermott Skip to main content

McDermott Will & Schulte advises H.I.G. Capital in the sale of Celerion

Überblick


Global law firm McDermott Will & Schulte represented H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $74 billion of capital under management, in the sale of Celerion Holdings, Inc. (“Celerion”) a global CRO and leader in clinical pharmacology and bioanalytical sciences, to funds affiliated with THL Partners.

The McDermott team was led by Harris Siskind, Alex Clavero, and Jun Won Kim with invaluable support from Michael Kim, Valeria Chavez, Adam Perlman, Galen Spielman, Noah Feldman Greene, Francesca Casalone, Dave Santangelo, Greg Heltzer, Kelly Holloway, Anthony Teng, Stéphane Dionnet, Mark Bilut, Alex Ruiz, Kate Vera Coverdale, Deepak Tamasker, Myriem Bennani, Wendy Phinny, Gregg Fierman, Allison Wilkerson, Darshak Dholakia, Jiayan Chen, Carolin Schumacher and Daniel Zucker.

Read H.I.G. Capital’s press release here.

Über uns


Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,700+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.

Ansprechpartner